Skip to main content
. Author manuscript; available in PMC: 2023 Nov 8.
Published in final edited form as: Nat Genet. 2023 May 8;55(5):796–806. doi: 10.1038/s41588-023-01384-0

Table 2 |.

Putative causal variants and coding variants in LD (r2 > 0.5) with index variants in EAS loci

Varianta rsID Subtype ORb P b Gene AA change EAS_MAF EUR_MAF R2c PIPd Tiere
chr1:67182913:G:A rs76418789 IBDf 0.57 2.0E-34 IL23R G149R 0.053 0.002 1.00 1.00 1
chr1:154962487:G:A rs3766920 CD 1.46 7.3E-13 SHC1 h 0.050 0.000 1.00 1.00 1
chr10:62710915:C:T rs224136 CD 0.76 5.5E-27 ADO 0.303 0.182 1.00 1.00 1
chr19:3548233:A:G rs2240751 CD 1.17 5.0E-09 MFSD12 Y182H 0.269 0.010 1.00 0.99 1
chr20:63744874:T:C rs2427537 CD 0.71 1.2E-11 ZBTB46 0.044 0.470 0.23 0.97 1
chr10:110426390:C:T rs11195128 CD 1.33 6.0E-16 DUSP5 0.148 0.320 1.00 0.95 2
chr2:190704810:C:T rs142152795 CD 1.43 2.1E-09 NAB1 0.021 0.000 1.00 0.93 2
chr7:74711703:C:T rs117026326 CD 1.37 8.9E-11 GTF2I 0.073 0.016 1.00 0.91 2
chr16:85976134:T:C rs16940186 UC 1.27 8.8E-18 IRF8 0.258 0.175 1.00 0.89 2
chr4:38323415:T:C rs6856616 CD 1.33 4.0E-29 LINC02513 0.232 0.060 0.69 0.87 2
chr10:79286696:G:A rs1250566 CD 0.82 1.9E-17 ZMIZ1 0.340 0.282 1.00 0.55 2
chr17:39732988:C:CT rs34372308 UC 0.86 3.8E-10 MIEN1 0.440 0.305 1.00 0.52 2
chr22:36911669:C:T rs12628495 CD 1.27 8.2E-20 CSF2RB 0.339 0.090 1.00 0.52 2
chr19:48709897:T:C rs78966440 CD 1.17 1.5E-11 FUT2 0.497 0.000 0.31 0.52 2
chr1:161509955:A:G rs1801274 UC 0.84 8.5E-11 FCGR2A H167R 0.278 0.489 0.93 0.29 2
chr2:240630832:A:C rs3749172 IBDg 0.81 6.4E-28 GPR35 S325R 0.289 0.440 1.00 0.11 2
chr1:21981045:C:T rs7528405 IBD 1.14 2.1E-08 CELA3B R79W 0.245 0.008 0.98 - 3
chr1:24964519:A:T rs6672420 CD 0.86 4.6E-10 RUNX3 I18N 0.312 0.479 0.91 - 3
chr1:28150351:G:T rs5938 CD 1.27 3.2E-08 PTAFR A224D 0.115 0.000 0.73 - 3
chr1:154968787:G:A rs8191981 IBD 1.32 1.6E-08 SHC1 h A205V 0.050 0.000 1.00 - 3
chr2:233274722:A:G rs2241880 CD 1.15 3.0E-09 ATG16L1 T317A 0.322 0.463 0.98 - 3
chr7:955367:G:C rs79805216 IBD 0.83 2.0E-13 ADAP1 P14R 0.205 0.018 0.95 - 3
chr7:1093055:C:T rs1133041 IBD 0.86 1.2E-09 GPER1 L349F 0.158 0.013 0.53 - 3
chr7:1093188:TTC:T rs3840681 IBD 0.86 1.2E-09 GPER1 FL393-394FX 0.157 0.014 0.53 - 3
chr12:109953174:T:C rs925368 CD 0.73 3.8E-09 GIT2 N387S 0.072 0.000 0.96 - 3
chr13:43883789:A:G rs3764147 CD 1.22 1.3E-17 LACC1 I254V 0.347 0.227 1.00 - 3
chr14:87941544:A:G rs398607 IBD 1.15 4.6E-09 GALC I562T 0.231 0.488 0.60 - 3
chr14:88011538:A:C rs3742704 IBD 1.19 2.8E-12 GPR65 I231L 0.206 0.099 0.71 - 3
chr16:28496323:C:G rs180743 CD 1.27 3.9E-12 APOBR P428A 0.104 0.348 0.78 - 3
chr16:28502082:A:G rs181206 CD 1.29 5.5E-13 IL27 L119P 0.083 0.287 0.97 - 3
chr16:28592334:T:G rs1059491 CD 1.28 7.4E-13 SULT1A2 N235T 0.074 0.317 0.81 - 3
chr16:28595911:A:G rs1136703 CD 1.29 3.6E-13 SULT1A2 I7T 0.073 0.310 0.80 - 3
chr17:39727784:C:G rs1058808 UC 1.15 9.2E-09 ERBB2 P1170A 0.402 0.327 0.93 - 3
chr17:59886176:A:G rs1292053 IBD 1.11 5.6E-09 TUBD1 M76T 0.425 0.418 1.00 - 3
chr19:48751247:G:A rs2071699 IBD 1.13 3.2E-10 FUT1 A12V 0.313 0.022 1.00 - 3
chr19:54219486:A:G rs255774 CD 1.23 2.4E-08 LILRB3 Splice donor 0.486 0.482 1.00 - 3
chr22:21628603:C:T rs2298428 IBD 1.16 4.0E-14 YDJC A263T 0.412 0.177 1.00 - 3
chr22:36875840:T:C rs2075939 CD 0.83 1.6E-14 NCF4 L272P 0.318 0.164 0.50 - 3
a

Variant annotated as CHR:POS:A1:A2. CHR, chromosome; POS, genomic position in genome build 38; A1, reference allele; A2, effect allele.

b

OR and P-value are from the meta-analysis including all EAS samples. P-value is from the inverse-variance-weighted fixed-effect meta-analysis (two-tailed).

c

R2, LD with the index variant measured as r2 using the 1000 genomes EAS individuals.

d

PIP, posterior inclusion probability.

e

Tier, 1 (PIP > 95% in EAS); 2 (PIP > 50%, or PIP > 10% if missense or predicted loss-of-function); 3 (missense variants tagging the index variants with r2 > 0.5).

f

rs76418789 has PIP = 1 for both CD and UC and was therefore listed as PIP = 1 for IBD.

g

rs3749172 has PIP = 0.11 and 0.09 for CD and UC, respectively, and was therefore listed as PIP = 0.11 with IBD.

h

The two SHC1 variants are in incomplete LD in study samples and complete LD in 1000 genomes EAS (rs3766920 has higher significance). We boldfaced variants implicating new IBD loci for tiers 1 and 2, and variants that had not reached genome-wide significance nor been identified as putative causal in previous studies4,5,7,8,12,3443 for tier 3.